Table 1.
Model | Method | Result | Positives | Negatives | Reference |
---|---|---|---|---|---|
Developmental desynchronization | Intracortical or hippocampal infusion of TTX at P14 | Spontaneous spasms at P24; abnormal EEG | Tests hypothesis of a ‘final common pathway’ | Late age for spasms | Lee et al., 2008 |
Down’s inhibition | Down’s syndrome mouse model with IP injections of GABA | Provoked spasms from 1 week to 2 months of age; abnormal EEG | Down’s syndrome is a known genetic cause of IS; tests role of inhibitory networks in IS | Provoked spasms | Cortez et al., 2009 |
Remote symptomatic causes | P3 injection of LPS and doxorubicin into cortex, followed by IP injection of PCPA | Spontaneous spasms at P10; abnormal EEG | Models the most common group of causes of IS; correct age of spasms | Only available in abstract form; severe damage to the cortex | Scantlebury and Moshe, 2006 |
Directed therapies model | IP injection of NMDA | Provoked spasms at P15; abnormal EEG | Developed as a way to test therapies to stop spasms; correct age | Provoked spasms; does not test mechanism or hypothesis of spasm generation | Kabova et al., 1999; Velísek et al., 2007 |
Interneuronopathy | Conditional Arx knockout | Convulsive seizures that evolve to spasms in adult mice; abnormal EEG | Seizures that evolve; spasms present; abnormal EEG; tests the hypothesis of interneuronal dysfunction | Late age for spasms; Arx mutations rarely cause IS | Marsh et al., 2009 |
All five models described in the text are listed with the model, method and concise findings. The positive and negative features of each model are also listed. Abbreviations: P, postnatal day; TTX, tetrodotoxin; IP, intraperitoneal; IS, infantile spasms; LPS, lipopolysaccharide; PCPA, p-chlorophenylalanine; Arx, aristaless-related homeobox gene.